IFIH1 and dermatomyositis: Therefore, glucocorticoids combined with one or more immunosuppressants may offer a basic treatment approach in cases of anti-MDA5+/ARS+ DM. In our cohort, IVIG was more commonly used in anti-MDA5+/ARS+ DM compared to anti-MDA5-/ARS+ DM.